Ultralife Corporation (NASDAQ:ULBI) specializes in providing power solutions and communications systems across government, defense, and commercial markets. Despite facing stiff competition in the power and communications industry, ULBI continues to navigate its market presence.
On March 10, 2026, ULBI disclosed its financial performance, revealing an EPS of -$0.45, which fell short of the anticipated $0.24. This discrepancy was primarily due to a $0.57 impact from an intangible asset impairment charge. Furthermore, the company's reported revenue of $48.5 million also did not meet the expected $57 million.
Despite the earnings shortfall, ULBI's fourth-quarter sales rose to $48.5 million from $43.9 million in the corresponding period of 2024. The gross profit for the quarter stood at $12.1 million, or 24.9% of revenue, marking an improvement from the prior year's 24.2%. However, the company recorded an operating loss of $10.6 million, attributed to a $12.2 million intangible asset impairment charge and $1.2 million in one-time costs.
The company's adjusted EBITDA saw an uptick to $5.7 million from $3.9 million in the preceding year, showcasing better operational efficiency. Additionally, ULBI concluded 2025 with a backlog of $110.2 million, an increase from $90.3 million at the end of the third quarter, which signals strong future demand for its offerings.
From a financial health perspective, ULBI's ratios such as a price-to-sales ratio of 0.54, and enterprise value to sales ratio of 0.78 offer insights into its market valuation. The company's debt-to-equity ratio of 0.39 and a current ratio of 2.99 reflect a robust liquidity position, underpinning its financial stability.
